CO5210869A1 - Una combinacion sinergetica: gabapentina y pregabalina - Google Patents

Una combinacion sinergetica: gabapentina y pregabalina

Info

Publication number
CO5210869A1
CO5210869A1 CO00049385A CO00049385A CO5210869A1 CO 5210869 A1 CO5210869 A1 CO 5210869A1 CO 00049385 A CO00049385 A CO 00049385A CO 00049385 A CO00049385 A CO 00049385A CO 5210869 A1 CO5210869 A1 CO 5210869A1
Authority
CO
Colombia
Prior art keywords
pregabalina
gabapentina
synergetic combination
hydrate
pharmaceutically acceptable
Prior art date
Application number
CO00049385A
Other languages
English (en)
Inventor
Roger N Brumel
Lakhbir Singh
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of CO5210869A1 publication Critical patent/CO5210869A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición Farmacéutica de efecto sinergético que comprende una cantidad terapéuticamente efectiva de gabapentina o una sal o hidrato farmacéuticamente aceptable de lo mismo y una cantidad terapéuticamente efectiva de pregabalina o una sal o hidrato farmacéuticamente aceptable de lo mismo.
CO00049385A 1999-07-02 2000-06-30 Una combinacion sinergetica: gabapentina y pregabalina CO5210869A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14221599P 1999-07-02 1999-07-02

Publications (1)

Publication Number Publication Date
CO5210869A1 true CO5210869A1 (es) 2002-10-30

Family

ID=22499016

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00049385A CO5210869A1 (es) 1999-07-02 2000-06-30 Una combinacion sinergetica: gabapentina y pregabalina

Country Status (14)

Country Link
EP (1) EP1196160B1 (es)
JP (1) JP2003503453A (es)
AR (1) AR030024A1 (es)
AT (1) ATE313322T1 (es)
AU (1) AU5753900A (es)
BR (1) BR0012058A (es)
CA (1) CA2373953A1 (es)
CO (1) CO5210869A1 (es)
DE (1) DE60024995T2 (es)
ES (1) ES2255500T3 (es)
MX (1) MXPA02000170A (es)
PE (1) PE20010331A1 (es)
UY (1) UY26230A1 (es)
WO (1) WO2001001983A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
WO2003066040A1 (fr) 2002-02-05 2003-08-14 Ajinomoto Co.,Inc. Compositions medicinales contenant une gabapentine ou une pregabaline et antagoniste a canal de calcium de type n
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
WO2004084880A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
DE602004003172T2 (de) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
JP2005060311A (ja) * 2003-08-13 2005-03-10 Mochida Pharmaceut Co Ltd Ｎ−（ベンゾイル）アミノ酸誘導体を有効成分とするニューロパシー性疼痛治療剤
DE102007019071A1 (de) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
WO2010036937A1 (en) 2008-09-27 2010-04-01 Taraxos Inc. Topical formulations for treatment of neuropathy
WO2010115612A2 (en) * 2009-04-10 2010-10-14 Synthon B.V. Pregabalin compositions
KR102074089B1 (ko) 2009-12-04 2020-02-05 선오비온 파마슈티컬스 인코포레이티드 다환형 화합물 및 이의 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194459B1 (en) * 1997-08-19 2001-02-27 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
DE19802327A1 (de) * 1998-01-23 1999-07-29 Goedecke Ag Synergistische Arzneimittelzubereitung mit analgetischer Wirkung
EP1161263A1 (en) * 1999-03-10 2001-12-12 Warner-Lambert Company Llc Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
DE60024995D1 (de) 2006-01-26
ES2255500T3 (es) 2006-07-01
EP1196160B1 (en) 2005-12-21
JP2003503453A (ja) 2003-01-28
ATE313322T1 (de) 2006-01-15
AR030024A1 (es) 2003-08-13
AU5753900A (en) 2001-01-22
EP1196160A1 (en) 2002-04-17
UY26230A1 (es) 2001-03-16
DE60024995T2 (de) 2006-06-22
CA2373953A1 (en) 2001-01-11
WO2001001983A1 (en) 2001-01-11
PE20010331A1 (es) 2001-03-22
BR0012058A (pt) 2002-05-14
MXPA02000170A (es) 2002-07-02

Similar Documents

Publication Publication Date Title
HK1070305A1 (en) Pharmaceutical composition comprising gabapentin or an analogue thereof and an sg(a)-aminoamide and its analgesic use
BR0115411A (pt) Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares
CA2370030A1 (en) Sodium channel blocker compositions and the use thereof
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
HUP0301194A3 (en) Pharmaceutical compositions containing combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents and their use for the treatment of diabete mellitus
EE200000770A (et) Farnesüülproteiintransferaasi inhibiitorite kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud artropaatiate raviks
EE200100618A (et) Dieet- või farmatseutiline kompositsioon kasutamiseks hüperoksaluuria vältimiseks või raviks
BR0008323A (pt) Derivado de gabapentina para a prevenção e o tratamento de dor visceral
CO5210869A1 (es) Una combinacion sinergetica: gabapentina y pregabalina
ES2192101T3 (es) Formas cristalinas de eto2c-ch2-(r)cgl-aze-pab-oh.
BR9714145B1 (pt) composto ou seu sal farmaceuticamente aceitável e composição farmacêutica compreendendo o mencionado composto.
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
EE05534B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks kardiomopaatia raviks ja/v?i ennetamiseks
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR0212989A (pt) Métodos para tratamento neuroprotetor usando inibidores de inos seletivos
CO5060499A1 (es) Metodos y composiciones para el tratamiento de enfermedad de reflujo gastroesofagico
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
WO2002006480A3 (en) Tissue inhibitors of matrix metalloproteinases
PA8483301A1 (es) Concentrado oral de sertralina
HUP0300576A2 (hu) Érkárosító hatású, osztott dózisú gyógyászati készítmény
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas

Legal Events

Date Code Title Description
FC Application refused